The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide
- PMID: 9681711
- DOI: 10.1093/ndt/13.7.1682
The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide
Abstract
Background: Dietary sodium restriction enhances the antiproteinuric and blood pressure lowering effect of ACE inhibition. In clinical practice, however, long-term compliance to a low-sodium diet may be difficult to obtain. We therefore investigated whether the blunting of the antiproteinuric and blood pressure lowering efficacy of ACE inhibition by high sodium intake can be restored by the addition of a diuretic.
Patients and methods: Seven proteinuric patients with non-diabetic renal disease on chronic ACE inhibition were studied during three consecutive 4-week periods: low sodium (50 mmol/day), high sodium (200 mmol/day) and high sodium plus hydrochlorothiazide (50 mg o.i.d.).
Results: During low sodium intake proteinuria was 3.1 (0.7-5.2) g/day, during high sodium intake proteinuria increased to 4.5 (1.6-9.2) g/day (P < 0.05). Interestingly, addition of hydrochlorothiazide again reduced proteinuria to 2.8 (0.6-5.8) g/day (P < 0.05). Mean arterial blood pressure was 89 (84-96), 98 (91-104) and 89 (83-94) mmHg (P < 0.05) during the three periods, respectively.
Conclusion: Addition of hydrochlorothiazide can overcome the blunting of the therapeutic efficacy of ACE inhibition on proteinuria and blood pressure by a high sodium intake.
Similar articles
-
Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.BMJ. 2011 Jul 26;343:d4366. doi: 10.1136/bmj.d4366. BMJ. 2011. PMID: 21791491 Free PMC article. Clinical Trial.
-
Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.Kidney Int. 1989 Aug;36(2):272-9. doi: 10.1038/ki.1989.190. Kidney Int. 1989. PMID: 2550696 Clinical Trial.
-
Combination of enalapril and low-dose thiazide reduces normoalbuminuria in essential hypertension.J Hypertens. 1998 Oct;16(10):1539-44. doi: 10.1097/00004872-199816100-00020. J Hypertens. 1998. PMID: 9814627 Clinical Trial.
-
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.Minerva Cardioangiol. 2002 Jun;50(3):169-74. Minerva Cardioangiol. 2002. PMID: 12107398 Review.
-
Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide.Am J Cardiovasc Drugs. 2005;5(1):17-22. doi: 10.2165/00129784-200505010-00003. Am J Cardiovasc Drugs. 2005. PMID: 15631534 Review.
Cited by
-
Thiazide diuretics are back in CKD: the case of chlorthalidone.Clin Kidney J. 2022 Sep 7;16(1):41-51. doi: 10.1093/ckj/sfac198. eCollection 2023 Jan. Clin Kidney J. 2022. PMID: 36726437 Free PMC article. Review.
-
Salt restriction in kidney disease--a missed therapeutic opportunity?Pediatr Nephrol. 2009 Jan;24(1):9-17. doi: 10.1007/s00467-008-0856-4. Epub 2008 Jun 6. Pediatr Nephrol. 2009. PMID: 18535843 Free PMC article. Review.
-
Does dietary salt increase the risk for progression of kidney disease?Curr Hypertens Rep. 2005 Oct;7(5):385-91. doi: 10.1007/s11906-005-0076-2. Curr Hypertens Rep. 2005. PMID: 16157084 Review.
-
Hypertension management in patients with chronic kidney disease.Curr Hypertens Rep. 2008 Oct;10(5):367-73. doi: 10.1007/s11906-008-0069-z. Curr Hypertens Rep. 2008. PMID: 18775113 Review.
-
Therapeutic roles of thiazides and loop diuretics in blood pressure control and renal protection against chronic kidney disease.Clin Hypertens. 2023 May 15;29(1):14. doi: 10.1186/s40885-023-00238-5. Clin Hypertens. 2023. PMID: 37183259 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous